| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 1L1V1K2M4V |
| InChI Key | ZJXIUGNEAIHSBI-IBGZPJMESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H24FN3O3S |
| Molecular Weight | 477.56 |
| AlogP | 5.43 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 75.44 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 34.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Orexin receptor 1 antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Orexin receptor
|
- | - | - | 0-9 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sleep Initiation and Maintenance Disorders | 2 | D007319 | ClinicalTrials |
| Sleep Wake Disorders | 1 | D012893 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 380899-24-1 |
| ChEMBL | CHEMBL1272307 |
| DrugBank | DB14822 |
| EPA CompTox | DTXSID90191491 |
| FDA SRS | 1L1V1K2M4V |
| Guide to Pharmacology | 4461 |
| PubChem | 25195495 |
| SureChEMBL | SCHEMBL8045969 |